KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Follow-up of humoral immune response after HPV vaccination using first-void urine: A longitudinal cohort study.

Laura Téblick, Jade Pattyn, Severien Van Keer, Annemie De Smet, Ilse De Coster, Wiebren A A Tjalma, Ira Rajbhandari, Gitika Panicker, Elizabeth R Unger, Alex Vorsters

J Med Virol 95(10) e29133

PMID37812015
PMCIDPMC11057001
DOI10.1002/jmv.29133
发表日期2023-10-09
摘要

摘要

Assessment of humoral immune responses following human papillomavirus (HPV) vaccination currently relies on invasive blood sampling. This longitudinal cohort study explores the usability of first-void urine as a noninvasive alternative sample for antibody detection. In this study, 58 women receiving three doses of the 9vHPV vaccine within a Gardasil9 (9vHPV) Phase III randomized controlled trial were included. Participants provided paired first-void urine and blood samples before vaccination (M0), 1 month after the third dose (M7), and ~3 years after the third dose (M43). Type-specific antibody responses to the 9vHPV types were analyzed in 174 first-void urine and 172 serum samples using a virus-like particle-based IgG multiplex enzyme-linked immunosorbent assay. Additionally, total human IgG concentrations were determined using the BioPlex assay. At M7, 1 month after complete 9vHPV vaccination, 95%-100% of first-void urine and 100% of serum samples had detectable concentrations, varying by HPV type. At M43, 84%-100% of first-void urine and 98%-100% of serum samples had HPV-specific antibody concentrations. Results show significant Spearman rank correlations between type-specific HPV-antibody concentrations for paired first-void urine and serum at all time points. This study confirms the potential feasibility of utilizing first-void urine as a noninvasive immunological sample within HPV vaccine trials.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。